Novel Insights in TKI Resistance in BCR:: ABL1-Positive B-Cell Acute Lymphoblastic Leukemia Beyond Kinase Domain Mutations

被引：1
|
作者：
Van Outersterp, Inge [1 ]
Reichert, Caitlin E. J. [1 ]
Boeree, Aurelie [1 ]
Van de Ven, Cesca [1 ]
Kruisinga, Brian [1 ]
de Groot-Kruseman, Hester A. [1 ]
Escherich, Gabriele [2 ]
Rijneveld, Anita W. [3 ]
Boer, Judith M. [1 ]
den Boer, Monique L. [1 ,4 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrectht, Netherlands
[2] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, Hamburg, Germany
[3] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Pediat Oncol Hematol, Sophia Childrens Hosp, Rotterdam, Netherlands
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179704
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] INCREASING BCR-ABL EXPRESSION LEVELS AND/OR OCCURRENCE OF ABL POINT MUTATIONS NOT ALWAYS PREDICT RESISTANCE TO IMATINIB MESYLATE IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Grammatico, S.
    Elia, L.
    Vitale, A.
    Matarazzo, M.
    Falciani, V
    Rago, A.
    Cenfra, N.
    Peluso, A. L.
    Pedace, L.
    Grammatico, P.
    Pane, F.
    Meloni, G.
    Foa, R.
    Cimino, G.
    HAEMATOLOGICA, 2008, 93 : S88 - S89
  • [42] Modelling of TKI Resistance In CML Cell Lines: Kinase Domain Mutations Usually Arise In the Setting of BCR-ABL Overexpression
    Tang, Carine
    Schafranek, Lisa
    Watkins, Dale
    Parker, Wendy T.
    Prime, Jodi
    White, Deborah L.
    Hughes, Timothy
    BLOOD, 2010, 116 (21) : 1385 - 1385
  • [43] Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
    Maletzke, Saskia
    Salimi, Azam
    Vieri, Margherita
    Schroeder, Kema Marlen
    Schemionek, Mirle
    Masouleh, Behzad Kharabi
    Brummendorf, Tim H.
    Koschmieder, Steffen
    Appelmann, Iris
    PLOS ONE, 2022, 17 (10):
  • [44] IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME
    Iacobucci, I.
    Storlazzi, C. T.
    Lonetti, A.
    Ferrari, A.
    Ottaviani, E.
    Chiaretti, S.
    Messina, M.
    Cilloni, D.
    Baldazzi, C.
    Papayannidis, C.
    Messa, F.
    Astolfi, A.
    Durante, S.
    Vitale, A.
    Arruga, F.
    Pane, F.
    Piccaluga, P. P.
    Colarossi, S.
    Soverini, S.
    Vignetti, M.
    Paolini, S.
    Saglio, G.
    Baccarani, M.
    Foa, R.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 428 - 428
  • [45] AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profile
    Messina, Monica
    Chiaretti, Sabina
    Iacobucci, Ilaria
    Tavolaro, Simona
    Lonetti, Annalisa
    Santangelo, Simona
    Elia, Loredana
    Papayannidis, Cristina
    Paoloni, Francesca
    Vitale, Antonella
    Guarini, Anna
    Martinelli, Giovanni
    Foa, Robin
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (06) : 727 - 732
  • [46] Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
    Jan Zuna
    Lenka Hovorkova
    Justina Krotka
    Amelie Koehrmann
    Michela Bardini
    Lucie Winkowska
    Eva Fronkova
    Julia Alten
    Rolf Koehler
    Cornelia Eckert
    Lisa Brizzolara
    Marie Trkova
    Jan Stuchly
    Martin Zimmermann
    Paola De Lorenzo
    Maria Grazia Valsecchi
    Valentino Conter
    Jan Stary
    Martin Schrappe
    Andrea Biondi
    Jan Trka
    Marketa Zaliova
    Giovanni Cazzaniga
    Gunnar Cario
    Leukemia, 2022, 36 : 2793 - 2801
  • [47] Blnk/Hdac9 maintains the nuclear localization of Foxo1 through supressing BCR-ABL1 kinase activity in BCR-ABL1+ B-cell acute lymphoblastic leukemia
    Zhang, P.
    Yu, X.
    Yuan, M.
    Wang, Y.
    Ji, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 324 - 324
  • [48] BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy
    Yamada, Chika
    Shimomura, Yoshimitsu
    Kamijyo, Kimimori
    Kanda-Kato, Madoka
    Yoshioka, Satoshi
    Yamashita, Daisuke
    Ishikawa, Takayuki
    INTERNAL MEDICINE, 2021, 60 (19) : 3149 - 3153
  • [49] Clinical implications of cytogenetic heterogeneities in BCR-ABL1 fusion positive adult B cell acute lymphoblastic leukemia
    Lu, Xinyan
    CANCER GENETICS, 2018, 224 : 53 - 53
  • [50] Clinical Implications of Cytogenetic Heterogeneity in BCR-ABL1 Fusion Positive Adult B Cell Acute Lymphoblastic Leukemia
    Lu, X.
    Medeiros, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S6 - S6
12345